TB Dispensary Arkhangelsk, Northern Russia
In Russia, MSF is collaborating with health authorities and academic partners in Arkhangelsk region to reduce the burden of drug-resistant tuberculosis and improve treatment for the disease.

In 2019, our teams in Arkhangelsk region began providing drugs and technical advice to support the treatment of patients with the most severe forms of TB in line with the latest World Health Organization recommendations. We are currently supporting the treatment of dozens of patients.

In partnership with Arkhangelsk Regional Ministry of Health, Northern State Medical University and Arkhangelsk Clinical TB Dispensary, we are building on existing expertise and working together to implement new all-oral short-course regimens. The aim of the collaboration is to provide evidence for future developments in TB policy in Russia and increase the availability of more effective models of treatment.  

MSF teams are also responding to the COVID-19 pandemic.

Our teams have been working in Russia since the early 1990s, running programmes in Moscow, Saint Petersburg, Kemerovo region, Chechnya, Ingushetia and Dagestan. 

Our activities in 2020 in Russia

Data and information from the International Activity Report 2020.

MSF in Russia in 2020 In Russia, MSF provides drugs and technical advice to support the treatment of patients with the most severe forms of TB. In 2020, we launched several new activities.
Russia Activities 2020

During the COVID-19 pandemic, MSF supported drug-resistant TB (DR-TB) patients with food parcels and health education about infection prevention measures. We also donated laboratory materials to Ministry of Health partners conducting COVID-19 testing.

In addition to our ongoing partnership with Arkhangelsk Regional Ministry of Health, Northern State Medical University and Arkhangelsk Clinical TB Dispensary, we entered into a technical agreement with the Regional TB Control Centre in Vladimir, to build on existing expertise and work together to implement novel, all-oral, short-course treatment regimens.

A study on oral short-course DR-TB regimens was approved by the Ethical Review Board of MSF and Ethical Research Committee of Northern State Medical University, with patient enrolment expected to begin in early 2021. The purpose of conducting the study in Arkhangelsk and Vladimir regions is to provide evidence for future developments in TB policy in Russia, and increase the availability of effective models of treatment that are more tolerable for patients.

In Moscow and Saint Petersburg, we work with two civil society organisations who offer high-quality healthcare to vulnerable people, including those living with HIV. People who are excluded from access to health clinics receive medical care through fixed and mobile units operated by these partners and supported by MSF.

In addition, during the COVID-19 pandemic, we delivered training and health education on prevention measures, and gave material support for hygiene and personal protective equipment for people treated by the civil society organisations. The training was adapted so it could be delivered online.

 

 
Tuberculosis treatments yield promising results in the Chechen Republic
Russia

Tuberculosis treatments yield promising results in the Chechen Republic

Voices from the Field 10 Nov 2017
 
Russia

MSF closes mental health programme in Ingushetia

Project Update 23 Nov 2012
 
Russia

Emergency response to people affected by wood fires in Russia

Project Update 12 Aug 2010
 
Russia

Hope for peace in Ingushetia has given way to despair

Project Update 29 Sep 2009
 
Russia

Geneva court rules in favour of MSF in Dutch government case

Press Release 27 Feb 2008
 
Russia

MSF's mental health program in Ingushetia and Chechnya

Project Update 28 Jun 2006

Contact us

TB treatments yield promising results in the Chechen Republic
MSF Moscow

16 Malaya Dmitrovka street,
127006 Moscow,
Russian Federation